# Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

> **NCT07671508** · PHASE2,PHASE3 · COMPLETED · sponsor: **MIPO Clinic** · enrollment: 75 (actual)

## Conditions studied

- Malignant Neoplasms
- Tuberculosis (TB)
- HEPATITIS C (HCV)

## Interventions

- **DRUG:** Naderin
- **OTHER:** Standard Therapy

## Key facts

- **NCT ID:** NCT07671508
- **Lead sponsor:** MIPO Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-15
- **Primary completion:** 2013-09-21
- **Final completion:** 2014-03-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671508, "Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*